Synopsis
0
EU WC
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
26
PharmaCompass offers a list of Nicergoline API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nicergoline manufacturer or Nicergoline supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nicergoline manufacturer or Nicergoline supplier.
PharmaCompass also assists you with knowing the Nicergoline API Price utilized in the formulation of products. Nicergoline API Price is not always fixed or binding as the Nicergoline Price is obtained through a variety of data sources. The Nicergoline Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Nicergolin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nicergolin, including repackagers and relabelers. The FDA regulates Nicergolin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nicergolin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nicergolin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nicergolin supplier is an individual or a company that provides Nicergolin active pharmaceutical ingredient (API) or Nicergolin finished formulations upon request. The Nicergolin suppliers may include Nicergolin API manufacturers, exporters, distributors and traders.
click here to find a list of Nicergolin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Nicergolin DMF (Drug Master File) is a document detailing the whole manufacturing process of Nicergolin active pharmaceutical ingredient (API) in detail. Different forms of Nicergolin DMFs exist exist since differing nations have different regulations, such as Nicergolin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Nicergolin DMF submitted to regulatory agencies in the US is known as a USDMF. Nicergolin USDMF includes data on Nicergolin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Nicergolin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Nicergolin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Nicergolin Drug Master File in Japan (Nicergolin JDMF) empowers Nicergolin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Nicergolin JDMF during the approval evaluation for pharmaceutical products. At the time of Nicergolin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Nicergolin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Nicergolin Drug Master File in Korea (Nicergolin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Nicergolin. The MFDS reviews the Nicergolin KDMF as part of the drug registration process and uses the information provided in the Nicergolin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Nicergolin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Nicergolin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Nicergolin suppliers with KDMF on PharmaCompass.
A Nicergolin CEP of the European Pharmacopoeia monograph is often referred to as a Nicergolin Certificate of Suitability (COS). The purpose of a Nicergolin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Nicergolin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Nicergolin to their clients by showing that a Nicergolin CEP has been issued for it. The manufacturer submits a Nicergolin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Nicergolin CEP holder for the record. Additionally, the data presented in the Nicergolin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Nicergolin DMF.
A Nicergolin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Nicergolin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Nicergolin suppliers with CEP (COS) on PharmaCompass.
Nicergolin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nicergolin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nicergolin GMP manufacturer or Nicergolin GMP API supplier for your needs.
A Nicergolin CoA (Certificate of Analysis) is a formal document that attests to Nicergolin's compliance with Nicergolin specifications and serves as a tool for batch-level quality control.
Nicergolin CoA mostly includes findings from lab analyses of a specific batch. For each Nicergolin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nicergolin may be tested according to a variety of international standards, such as European Pharmacopoeia (Nicergolin EP), Nicergolin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nicergolin USP).
